Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
NCT04265157 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-02-11
Summary
Liver transplantation was historically associated with massive blood loss. Many factors have contributed to the decline in bleeding and transfusion in the past two decades including refinement of surgical techniques, anesthetics management and the use of point of care guided goal-directed hemostatic therapies. Increasing awareness of the adverse associations of allogenic transfusion has driven the quest for transfusion-free transplantation. Pre-operative management of preoperative anemia and targeted correction of coagulopathy is done to decrease blood transfusion. Liver transplantation is associated with the potential for massive operative blood loss, which has been recognized as one of the main causes of morbidity and mortality after liver transplantation. Therefore, a fine surgical procedure to reduce intraoperative hemorrhage is necessary for favorable outcomes of liver transplantation.
Conditions
- Liver Transplant
Interventions
- PROCEDURE
-
Surgical technique surgical occlusion
Occlusion of hepatoduodenal ligament by clamp or occlusive bands
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-31
- Primary Completion
- 2022-03-31
- Completion
- 2022-09-30
More Related Trials
-
Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.
NCT02352181 ·Status: COMPLETED ·Phase: NA
-
Fibrinogen in Liver Transplant Subjects
NCT06764927 ·Status: WITHDRAWN ·Phase: PHASE4
-
Fibrinogen in Liver Transplant
NCT07265843 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
NCT04383756 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)
NCT01874639 ·Status: UNKNOWN ·Phase: PHASE2
-
Transfusion Requirements After Orthotopic Liver Transplantation
NCT01435746 ·Status: WITHDRAWN ·Phase: NA
-
Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding
NCT03023189 ·Status: UNKNOWN ·Phase: PHASE4
-
Plasma Transfusion in Major Vascular Surgery
NCT04514575 ·Status: COMPLETED
-
Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection
NCT07125612 ·Status: COMPLETED
-
Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation
NCT03012633 ·Status: COMPLETED
-
Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation
NCT06307158 ·Status: COMPLETED
-
The Efficacy of the Administration of Fibrinogen in Liver Transplantation
NCT01539057 ·Status: UNKNOWN ·Phase: PHASE3
-
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation
NCT01711957 ·Status: UNKNOWN
-
Transfusion HeAd NecK Surgery
NCT03910816 ·Status: COMPLETED
-
Transfusion Strategies for Pediatric Liver Transplantation
NCT02951013 ·Status: UNKNOWN ·Phase: NA
-
Viscoelastic Tests-Guided Therapy In Liver Transplantation
NCT03756948 ·Status: COMPLETED ·Phase: NA
-
Von Willebrand Factor and Protein C Ratio in Graft Function After Liver Transplant
NCT04324255 ·Status: UNKNOWN
-
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
NCT00657384 ·Status: TERMINATED ·Phase: PHASE3
-
Is Redo Pediatric Cardiac Surgery a Risk Factor for Transfusion?
NCT04456751 ·Status: COMPLETED
-
Reperfusion-induced Self-antigen Excretion Following Major Liver Surgery
NCT01700660 ·Status: COMPLETED
-
Thrombin Generation in Liver Transplant Surgery
NCT04762550 ·Status: UNKNOWN
-
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
NCT03651154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
NCT06014320 ·Status: UNKNOWN
-
Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy
NCT02457403 ·Status: COMPLETED ·Phase: NA
-
Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients
NCT01654848 ·Status: COMPLETED